<?xml version="1.0" encoding="UTF-8"?>
<p>Xuejiao et al. reported the synthesis of a substituted pyridine based acetamide BTA derivative 
 <bold>30</bold> (
 <xref ref-type="fig" rid="F0018">Figure 18</xref>) and screened its anti-cancer activity both 
 <italic>in vitro</italic> and 
 <italic>in</italic> v
 <italic>ivo.</italic> Derivative 
 <bold>30</bold> demonstrated anti-proliferative activities against a wide spectrum of human cell lines and induced the mitochondrial apoptotic pathway in HepaG2 cell lines. The BTA scaffold 
 <bold>30</bold> proved to be a promising candidate for cancer chemotherapy
 <xref rid="CIT0037" ref-type="bibr">
  <sup>37</sup>
 </xref>.
</p>
